Acetyl-L-carnitine + alpha-lipoic acid + nicotinamide
Acetyl-L-carnitine + alpha-lipoic acid + nicotinamide has been studied in 1 paper since 2025: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Jan 1, 2025: “Mitochondria-targeting compounds for management of metabolic and hemostatic abnormalities associated with heart dysfunctions in experimental type 2 diabetes”.
See all 1 papers on acetyl-L-carnitine + alpha-lipoic acid + nicotinamide
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Animals1
What did studies of acetyl-L-carnitine + alpha-lipoic acid + nicotinamide find?
4Studies of acetyl-L-carnitine + alpha-lipoic acid + nicotinamide measured 4 outcomes, among them hemostatic abnormalities, NAD+ metabolism and HbA1c.
Hemostatic abnormalities
downin rats1
1 study
Hemostatic abnormalities
downin rats1
Acetyl-L-carnitine + alpha-lipoic acid + nicotinamide decreases hemostatic abnormalities in rats (high-calorie diet- and streptozotocin-induced type 2 diabetes) (Partial correction).
“partially corrected the hemostatic abnormalities.”
Animalshigh-calorie diet- and streptozotocin-induced type 2 diabetesacetyl-L-carnitine 100 mg/kg; alpha-lipoic acid 50 mg/kg; nicotinamide 100 mg/kg2 weeksmales
Endocrine regulations
NAD+ metabolism
upin rats1
1 study
NAD+ metabolism
upin rats1
Acetyl-L-carnitine + alpha-lipoic acid + nicotinamide improves NAD+ metabolism in rats (high-calorie diet- and streptozotocin-induced type 2 diabetes).
“partially restored the cardiac NAD+ metabolism”
Animalshigh-calorie diet- and streptozotocin-induced type 2 diabetesheartacetyl-L-carnitine 100 mg/kg; alpha-lipoic acid 50 mg/kg; nicotinamide 100 mg/kg2 weeksmales
Endocrine regulations
HbA1c
downin rats1
1 study
HbA1c
downin rats1
Acetyl-L-carnitine + alpha-lipoic acid + nicotinamide decreases HbA1c in rats (high-calorie diet- and streptozotocin-induced type 2 diabetes) (1.7-fold reduction).
“Combined treatment lowered the glucose levels by 1.3-fold and HbA1c by 1.7-fold”
Animalshigh-calorie diet- and streptozotocin-induced type 2 diabetesbloodacetyl-L-carnitine 100 mg/kg; alpha-lipoic acid 50 mg/kg; nicotinamide 100 mg/kg2 weeksmales
Endocrine regulations
Fasting blood glucose
downin rats1
1 study
Fasting blood glucose
downin rats1
Acetyl-L-carnitine + alpha-lipoic acid + nicotinamide decreases fasting blood glucose in rats (high-calorie diet- and streptozotocin-induced type 2 diabetes) (1.3-fold reduction).
“Combined treatment lowered the glucose levels by 1.3-fold and HbA1c by 1.7-fold”
Animalshigh-calorie diet- and streptozotocin-induced type 2 diabetesbloodacetyl-L-carnitine 100 mg/kg; alpha-lipoic acid 50 mg/kg; nicotinamide 100 mg/kg2 weeksmales
Endocrine regulations